BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35294121)

  • 1. Shenweifang-containing serum inhibits transforming growth factor-β1 induced myofibroblast differentiation in normal rat kidney interstitial fibroblast cell.
    Lin J; Wang L; Chen B; Ou S; Qin J; Fan J
    J Tradit Chin Med; 2022 Feb; 42(1):39-48. PubMed ID: 35294121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lefty-1 alleviates TGF-β1-induced fibroblast-myofibroblast transdifferentiation in NRK-49F cells.
    Zhang L; Zhang J; Xu C; Zhou X; Wang W; Zheng R; Hu W; Wu P
    Drug Des Devel Ther; 2015; 9():4669-78. PubMed ID: 26316705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
    Lian R; Chen Y; Xu Z; Zhang X
    Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction.
    Yang J; Dai C; Liu Y
    Am J Pathol; 2003 Aug; 163(2):621-32. PubMed ID: 12875981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1].
    Guo W; Xu H; Huang WY; Chen J; Yang Y; Fu R; Liu HM; Zha XL; Zhang ZG
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1660-5. PubMed ID: 17825142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of TRPC6 suppressed TGFβ-induced fibroblast-myofibroblast transdifferentiation in renal interstitial NRK-49F cells.
    Jiang S; Gu L; Hu Y; Ren Y; Yang Z; Chai C; Yu B; Ge H; Cao Z; Zhao F
    Exp Cell Res; 2022 Dec; 421(1):113374. PubMed ID: 36206825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WISP3 prevents fibroblast-myofibroblast transdifferentiation in NRK-49F cells.
    Yi Y; Ma J; Jianrao L; Wang H; Zhao Y
    Biomed Pharmacother; 2018 Mar; 99():306-312. PubMed ID: 29353205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation.
    Chen LX; Yang K; Sun M; Chen Q; Wang ZH; Hu GY; Tao LJ
    Pharmazie; 2012 May; 67(5):452-6. PubMed ID: 22764581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gefitinib attenuates transforming growth factor-β1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells.
    Chen SC; Guh JY; Lin TD; Chiou SJ; Hwang CC; Ko YM; Chuang LY
    Transl Res; 2011 Oct; 158(4):214-24. PubMed ID: 21925118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-beta1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK.
    Khalil N; Xu YD; O'Connor R; Duronio V
    J Biol Chem; 2005 Dec; 280(52):43000-9. PubMed ID: 16246848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoxO1 mediates TGF-beta1-dependent cardiac myofibroblast differentiation.
    Vivar R; Humeres C; Muñoz C; Boza P; Bolivar S; Tapia F; Lavandero S; Chiong M; Diaz-Araya G
    Biochim Biophys Acta; 2016 Jan; 1863(1):128-38. PubMed ID: 26518453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of mitogen-activated protein kinase in the regulation of transforming growth factor-beta-induced fibronectin accumulation in cultured renal interstitial fibroblasts.
    Suzuki H; Uchida K; Nitta K; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):188-95. PubMed ID: 15480895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cordycepin inhibits renal interstitial myofibroblast activation probably by inducing hepatocyte growth factor expression.
    Li L; He D; Yang J; Wang X
    J Pharmacol Sci; 2011; 117(4):286-94. PubMed ID: 22134049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1.
    Ma J; Ma SY; Ding CH
    Chin J Integr Med; 2017 May; 23(5):362-369. PubMed ID: 26956464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-(1-7) decreases the expression of collagen I via TGF-β1/Smad2/3 and subsequently inhibits fibroblast-myofibroblast transition.
    Zhou JP; Tang W; Feng Y; Li N; Gu CJ; Li QY; Wan HY
    Clin Sci (Lond); 2016 Nov; 130(21):1983-1991. PubMed ID: 27543459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midbody plays an active role in fibroblast-myofibroblast transition by mediating TGF-β signaling.
    Jung SW; Kim SM; Kim A; Park SH; Moon JY; Lee SH
    FASEB J; 2022 May; 36(5):e22272. PubMed ID: 35436011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirtuin 6 inhibits myofibroblast differentiation via inactivating transforming growth factor-β1/Smad2 and nuclear factor-κB signaling pathways in human fetal lung fibroblasts.
    Zhang Q; Tu W; Tian K; Han L; Wang Q; Chen P; Zhou X
    J Cell Biochem; 2019 Jan; 120(1):93-104. PubMed ID: 30230565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AMPK agonist AICAR inhibits TGF-β1 induced activation of kidney myofibroblasts.
    Chen KH; Hsu HH; Lee CC; Yen TH; Ko YC; Yang CW; Hung CC
    PLoS One; 2014; 9(9):e106554. PubMed ID: 25188319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of the myofibroblastic phenotype in human gingival fibroblasts by transforming growth factor-beta1: role of RhoA-ROCK and c-Jun N-terminal kinase signaling pathways.
    Smith PC; Cáceres M; Martinez J
    J Periodontal Res; 2006 Oct; 41(5):418-25. PubMed ID: 16953819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutaminolysis is required for transforming growth factor-β1-induced myofibroblast differentiation and activation.
    Bernard K; Logsdon NJ; Benavides GA; Sanders Y; Zhang J; Darley-Usmar VM; Thannickal VJ
    J Biol Chem; 2018 Jan; 293(4):1218-1228. PubMed ID: 29222329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.